A Phase III Trial of Pertuzumab Retreatment in Previously Pertuzumab Treated Her2-Positive Advanced Breast Cancer

Clinical trial NCT02514681 · COMPLETED

Trial details

NCT number: NCT02514681
Sponsor: Japan Breast Cancer Research Group
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

HER2-positive Locally Advanced or Metastatic Breast Cancer

Start date: 2015-08-01
Primary completion: 2018-12-31
Enrollment: 226

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.